Source: Eur Respir J 2015; 45: 428-439
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Schögler Aline, Kopf Brigitte S., Edwards Michael R., Johnston Sebastian L., Casaulta Carmen, Kieninger Elisabeth, Jung Andreas, Moeller Alexander, Geiser Thomas, Regamey Nicolas, Alves Marco P.. Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells. Eur Respir J 2015; 45: 428-439

Member's Comments

No comment yet.

Related content which might interest you: Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022 Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Investigation of the status of cystic fibrosis airway epithelial cells Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy Year: 2008 Novel antiviral properties of vitamin D in cystic fibrosis airway epithelial cells Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Antiviral activity of azithromycin in cystic fibrosis airway epithelial cells Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Azithromycin fails to restore apoptosis in cystic fibrosis airway epithelium post viral infection Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011 An anti-inflammatory effect of azithromycin in cystic fibrosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Proteomics characterisation of nasal epithelial cells in cystic fibrosis Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Azithromycin induces anti-viral responses in bronchial epithelial cells Source: Eur Respir J 2010; 36: 646-654 Year: 2010 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Possible mechanisms of action of azithromycin in cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Distribution and characterisation of lung mast cells in cystic fibrosis Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Individual treatment of cystic fibrosis by using intestinal organoids Source: International Congress 2015 – Advancing therapies for cystic fibrosis Year: 2015 Inflammatory response upon viral infection in cystic fibrosis airway epithelial cells Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 Epithelial cell regulation of immunity in cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Lack of therapeutic potential for topical metformin in treatment of airway secretion dehydration in cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009